🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Severe Renal Impairment

Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal Function NCT07853131Phase 11 site📍 Hialeah Sanofi · Tests: rilzabrutinib Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial NCT06863194Phase 1, Phase 21 site📍 Al Mansurah Mansoura University · Tests: Probiotic Supplementation (Lactobacillus plantarum), Placebo Tablets A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation NCT06243731n/a25 sites📍 Anderlecht📍 Leuven📍 Tallinn Takeda · Tests: No Intervention Albumin and Prognosis of Severely Patients Burns NCT04264065n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial NCT06337838Phase 33 sites📍 London📍 Montreal📍 Montreal Hamilton Health Sciences Corporation · Tests: Desmopressin Injectable Solution, Tranexamic Acid Injectable Product, Placebo A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) NCT07734610Phase 11 site📍 Miami Lakes Merck Sharp & Dohme LLC · Tests: Nemtabrutinib Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury NCT06472999n/a3 sites📍 Innsbruck📍 Münster📍 Nijmegen Universität Münster · Tests: Nephroprotective measures Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus NCT06593392Phase 218 sites📍 Chengdu📍 Guangzhou📍 Guangzhou Vifor Fresenius Medical Care Renal Pharma · Tests: Difelikefalin Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock? NCT03547414n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: Nephrocheck test Swedish Cardiac And Renal Failure Study-1 NCT07029503Phase 21 site📍 Stockholm Karolinska Institutet · Tests: Eplerenone Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease NCT06725810Phase 41 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Enarodustat Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD NCT03836482NA1 site📍 Ann Arbor SeaStar Medical · Tests: Selective Cytopheretic Device Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease NCT05732727Phase 340 sites📍 Angers📍 Bordeaux📍 Brest University Hospital, Tours · Tests: Antihypertensive algorithm, Standard of care Mechanisms of Acute Kidney Injury in Severe Infections NCT06372444n/a1 site📍 Uppsala Uppsala University Hospital · Tests: Positron emission tomography (PET) DIALysis With EXpanded Solute Removal NCT06660277NA3 sites📍 London📍 Orillia📍 Ottawa London Health Sciences Centre Research Institute OR Lawson … · Tests: Super High-Flux Dialyzer, High-Flux Dialyzer Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease NCT05283512NA1 site📍 Odense C Odense University Hospital · Tests: Preventive treatment with IV-hydration, Preventive treatment with oral hydration Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment NCT04953897Phase 121 sites📍 Houston📍 Yerevan📍 Yerevan Taiho Oncology, Inc. · Tests: ASTX727 Renal and Hepatic Abnormal Doppler Patterns in Trauma NCT07492511n/a1 site📍 Bologna Azienda Usl di Bologna · Tests: Point of care ultrasound Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. NCT07464106n/a1 site📍 Stuttgart Robert Bosch Medical Center · Tests: Transcatheter edge-to-edge repair (TEER) Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD NCT04580420Phase 218 sites📍 San Francisco📍 Boston📍 Rochester Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · Tests: DCR-PHXC A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide NCT07793929Phase 12 sites📍 Orlando📍 San Antonio Kailera · Tests: Ribupatide Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease NCT07483372Phase 11 site📍 Suzhou The First Affiliated Hospital with Nanjing Medical Universi… · Tests: SC101 A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease NCT07559396Phase 12 sites📍 Miami Lakes📍 Orlando Incyte Corporation · Tests: INCB123667 The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis NCT03862859Phase 413 sites📍 Herlev📍 Hillerød📍 Aalborg Nicholas Carlson · Tests: Warfarin Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation NCT05679024Phase 334 sites📍 Helsinki📍 Tampere📍 Turku Region Stockholm · Tests: Apixaban 2.5 milligram Oral Tablet Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension NCT06291714NA1 site📍 Giessen University of Giessen · Tests: GDT-based hemodynamic management based on Clearsight device A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) NCT07241390Phase 3566 sites📍 Bahía Blanca📍 Buenos Aires📍 Buenos Aires Eli Lilly and Company · Tests: Orforglipron, Placebo Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis NCT07853677n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Nephroprotection in Severe Trauma Patients With Kidney Stress NCT06834633NA6 sites📍 Clermont-Ferrand📍 Épagny📍 La Tronche Hospices Civils de Lyon · Tests: Standard-of-care, Systematic nephroprotection bundle-of-care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy